Medicare Enrolled
Dr. Adrian Deme, MD
Optician · Arlington Heights, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deme from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deme?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deme
Dr. Adrian Deme is an optician specialist in Arlington Heights, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Deme performed 2,835 Medicare services across 1,647 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deme received a total of $15,808 from 58 pharmaceutical and/or device companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deme is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 23% volume in IL
$15,808 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,835
Medicare services
Top 23% in IL for optician
1,647
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
739 | $66 | $170 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
495 | $67 | $125 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
457 | $8 | $19 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
267 | $137 | $190 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
236 | $42 | $90 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
131 | $67 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
129 | $97 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
125 | $107 | $225 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
62 | $3 | $35 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
44 | $44 | $78 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $116 | $200 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
36 | $55 | $130 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
31 | $67 | $175 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
30 | $12 | $70 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
17 | $150 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,808
Total received (2018-2024)
Avg $2,258/year across 7 years
Top 6% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
890
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,243 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$564 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,548
2023
$2,679
2022
$2,445
2021
$2,082
2020
$1,966
2019
$2,144
2018
$1,945
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$369
AstraZeneca Pharmaceuticals LP
$303
PFIZER INC.
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
Lilly USA, LLC
$229
Lexicon Pharmaceuticals, Inc.
$216
Amgen Inc.
$211
GlaxoSmithKline, LLC.
$111
Astellas Pharma US Inc
$99
Novo Nordisk Inc
$93
Sumitomo Pharma America, Inc.
$53
IBSA Pharma Inc.
$53
Otsuka America Pharmaceutical, Inc.
$53
Exact Sciences Corporation
$47
Abbott Laboratories
$38
E.R. Squibb & Sons, L.L.C.
$34
Bayer Healthcare Pharmaceuticals Inc.
$31
Phathom Pharmaceuticals, Inc.
$21
Almatica Pharma LLC
$20
Novartis Pharmaceuticals Corporation
$20
Kowa Pharmaceuticals America, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Corcept Therapeutics
$15
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,936
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,655
PFIZER INC.
$1,347
Novo Nordisk Inc
$1,155
Lilly USA, LLC
$1,098
GlaxoSmithKline, LLC.
$994
Amgen Inc.
$949
AbbVie Inc.
$810
Astellas Pharma US Inc
$682
SANOFI-AVENTIS U.S. LLC
$599
Janssen Pharmaceuticals, Inc
$484
ABBVIE INC.
$452
E.R. Squibb & Sons, L.L.C.
$436
Novartis Pharmaceuticals Corporation
$347
Lexicon Pharmaceuticals, Inc.
$216
Biohaven Pharmaceutical Holding Company Ltd.
$201
Allergan, Inc.
$182
IBSA Pharma Inc.
$157
Exact Sciences Corporation
$150
Sunovion Pharmaceuticals Inc.
$148
Biogen, Inc.
$139
Bayer HealthCare Pharmaceuticals Inc.
$133
Otsuka America Pharmaceutical, Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$121
Corium, LLC
$97
Sumitomo Pharma America, Inc.
$93
OPKO Pharmaceuticals, LLC
$78
Biohaven Pharmaceuticals, Inc.
$73
Merck Sharp & Dohme Corporation
$71
Esperion Therapeutics, Inc.
$64
AbbVie, Inc.
$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$51
Amneal Pharmaceuticals LLC
$50
Allergan Inc.
$46
Abbott Laboratories
$38
Melinta Therapeutics, Inc.
$37
NOVARTIS PHARMACEUTICALS CORPORATION
$37
Almatica Pharma LLC
$36
IDORSIA PHARMACEUTICALS US INC
$34
Corcept Therapeutics
$34
Kowa Pharmaceuticals America, Inc.
$34
EISAI INC.
$33
Merck Sharp & Dohme LLC
$33
Edwards Lifesciences Corporation
$30
Lundbeck LLC
$27
JAZZ PHARMACEUTICALS INC.
$25
Alexion Pharmaceuticals, Inc.
$24
HARMONY BIOSCIENCES LLC
$22
Bausch Health US, LLC
$22
Phathom Pharmaceuticals, Inc.
$21
Circassia Pharmaceuticals Inc
$20
RedHill Biopharma Inc.
$20
Eisai Inc.
$17
Alfasigma USA, Inc.
$17
VIVUS, Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$15
Shionogi Inc
$15
Mission Pharmacal Company
$11
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIRSUPRA · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · Adlarity · Aimovig · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · Belviq · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · ENTRESTO · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FREESTYLE LIBRE 3 · Ferralet · GEMTESA · HUMALOG · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LIVALO · LOKELMA · LOREEV XR · LYRICA · Licart · Linzess · MOUNJARO · MOVANTIK · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NURTEC ODT · Otezla · Ozempic · PRADAXA · PREVNAR 13 · Prolia · QSYMIA · QULIPTA · QUVIVIQ · RAYALDEE · REXULTI · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Symproic · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tirosint · Tresiba · UBRELVY · ULTOMIRIS · UNITHROID · VOQUEZNA · VRAYLAR · Vabomere · Veozah · Victoza · Wakix · XARELTO · XIFAXAN · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for optician in IL.
Geographic Context
Opticians within 10 mi
775
Per 100K population
14.9
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deme is a clinical cardiology specialist, with above-average Medicare volume (top 23% in IL), with low-engagement industry engagement in the top 6% of IL peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deme experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Deme performed 739 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deme receive payments from pharmaceutical companies?
Yes. Dr. Deme received a total of $15,808 from 58 companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deme's costs compare to other opticians in Arlington Heights?
Dr. Deme's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deme) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Arlington Heights
Browse opticians in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology